Fort Sheridan Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.9M | Hold |
108,202
| – | – | 2.58% | 10 |
|
|
2026
Q1 | $32M | Buy |
108,202
+32
| +0% | +$9.51K | 3.86% | 5 |
|
|
2025
Q4 | $29.5M | Hold |
108,170
| – | – | 3.75% | 6 |
|
|
2025
Q3 | $29.2M | Hold |
108,170
| – | – | 3.82% | 4 |
|
|
2025
Q2 | $29.8M | Hold |
108,170
| – | – | 4.25% | 4 |
|
|
2025
Q1 | $28.7M | Hold |
108,170
| – | – | 4.36% | 4 |
|
|
2024
Q4 | $25.1M | Hold |
108,170
| – | – | 3.67% | 5 |
|
|
2024
Q3 | $23.9M | Buy |
108,170
+41
| +0% | +$8.48K | 3.62% | 4 |
|
|
2024
Q2 | $21.3M | Hold |
108,129
| – | – | 3.44% | 4 |
|
|
2024
Q1 | $23.3M | Sell |
108,129
-78,495
| -42% | -$16.5M | 4.39% | 4 |
|
|
2023
Q4 | $39.3M | Buy |
186,624
+275
| +0.1% | +$58.7K | 7.84% | 3 |
|
|
2023
Q3 | $37.3M | Hold |
186,349
| – | – | 8.46% | 3 |
|
|
2023
Q2 | $34.5M | Hold |
186,349
| – | – | 7.88% | 3 |
|
|
2023
Q1 | $35.7M | Buy |
186,349
+225
| +0.1% | +$40.7K | 9.06% | 3 |
|
|
2022
Q4 | $31.3M | Hold |
186,124
| – | – | 10.18% | 1 |
|
|
2022
Q3 | $33M | Hold |
186,124
| – | – | 11.11% | 1 |
|
|
2022
Q2 | $38.1M | Hold |
186,124
| – | – | 12.39% | 1 |
|
|
2022
Q1 | $44.3M | Sell |
186,124
-4,285
| -2% | -$1.01M | 12.99% | 1 |
|
|
2021
Q4 | $43.5M | Buy |
190,409
+10,611
| +6% | +$2.33M | 12.55% | 1 |
|
|
2021
Q3 | $34.8M | Sell |
179,798
-4,741
| -3% | -$961K | 11.38% | 1 |
|
|
2021
Q2 | $39.2M | Buy |
184,539
+116
| +0.1% | +$24.5K | 13.09% | 1 |
|
|
2021
Q1 | $37.7M | Sell |
184,423
-2,675
| -1% | -$527K | 14.95% | 1 |
|
|
2020
Q4 | $34.1M | Hold |
187,098
| – | – | 16.61% | 1 |
|
|
2020
Q3 | $31.3M | Buy |
187,098
+1,000
| +0.5% | +$168K | 18.54% | 1 |
|
|
2020
Q2 | $30.2M | Sell |
186,098
-234
| -0.1% | -$41.9K | 18.59% | 1 |
|
|
2020
Q1 | $32.2M | Sell |
186,332
-22,805
| -11% | -$4.54M | 23.74% | 1 |
|
|
2019
Q4 | $42M | Sell |
209,137
-4,489
| -2% | -$921K | 22.51% | 1 |
|
|
2019
Q3 | $45.1M | Sell |
213,626
-14,236
| -6% | -$2.97M | 25.28% | 1 |
|
|
2019
Q2 | $44.2M | Sell |
227,862
-655
| -0.3% | -$121K | 25.59% | 1 |
|
|
2019
Q1 | $37.6M | Sell |
228,517
-2,000
| -0.9% | -$354K | 24.62% | 1 |
|
|
2018
Q4 | $43.4M | Buy |
+230,517
| New | +$42.6M | 30.73% | 1 |
|
Other funds holding CME
Fort Sheridan Advisors's CME Position: Q2 2026 in Review
Fort Sheridan Advisors held its CME Group (CME) position steady in Q2 2026 at 108,202 shares worth $23.9M. The position accounts for 2.58% of the portfolio, ranked #10.
Fort Sheridan Advisors first reported a position in CME in Q4 2018 and has held it in 31 quarters since. The position peaked at $45.1M in Q3 2019. 1,702 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Fort Sheridan Advisors held 108,202 shares of CME Group worth $23.9M as of Q2 2026.
- Fort Sheridan Advisors left its CME Group share count unchanged in Q2 2026.
- CME Group made up 2.58% of Fort Sheridan Advisors's portfolio in Q2 2026, its #10 holding.
- Fort Sheridan Advisors first reported a position in CME Group in Q4 2018 and has held it in 31 quarters since.
- Fort Sheridan Advisors's CME Group position peaked at $45.1M in Q3 2019.
- 1,702 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.